Scemblix Evrópusambandið - íslenska - EMA (European Medicines Agency)

scemblix

novartis europharm limited - asciminib hydrochloride - kyrningahvítblæði, mergbreytilegt, langvinnt, bcr-abl jákvætt - Æxlishemjandi lyf - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.

Hirudoid Krem 3 mg/g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

hirudoid krem 3 mg/g

stada arzneimittel ag - heparinoidum ex organis animal - krem - 3 mg/g

Hirudoid Hlaup 3 mg/g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

hirudoid hlaup 3 mg/g

stada arzneimittel ag - heparinoidum ex organis animal - hlaup - 3 mg/g

Spikevax (previously COVID-19 Vaccine Moderna) Evrópusambandið - íslenska - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - bóluefni - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Depo-Medrol Stungulyf, dreifa 40 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

depo-medrol stungulyf, dreifa 40 mg/ml

pfizer aps - methylprednisolonum acetat - stungulyf, dreifa - 40 mg/ml

Azarga Evrópusambandið - íslenska - EMA (European Medicines Agency)

azarga

novartis europharm limited - skammtar, notkunar í augu. maleat - glaucoma, open-angle; ocular hypertension - augnlækningar - minnkuð augnþrýstingur (iop) hjá fullorðnum sjúklingum með gláku í augnlokum eða augnháþrýstingi, sem einlyfjameðferð veldur ófullnægjandi blóðsykursfalli.

Visudyne Evrópusambandið - íslenska - EMA (European Medicines Agency)

visudyne

cheplapharm arzneimittel gmbh - verteporfin - myopia, degenerative; macular degeneration - augnlækningar - visudyne er ætlað fyrir meðferð:fullorðnir með exudative (blautur) aldri-tengjast ský á auga (rÍsa) með aðallega klassískt subfoveal æðu neovascularisation (cnv) eða;fullorðnir með subfoveal æðu neovascularisation efri að sjúklegt nærsýni.

Onpattro Evrópusambandið - íslenska - EMA (European Medicines Agency)

onpattro

alnylam netherlands b.v. - patisiran járn - amyloidosis, Ættingja - Önnur lyf í taugakerfinu - onpattro er ætlað fyrir meðferð arfgenga transthyretin-miðlað amyloidosis (hattr amyloidosis) í fullorðinn sjúklinga með stigi 1 eða stigi 2 polyneuropathy.

Haldol Depot Stungulyf, lausn 100 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

haldol depot stungulyf, lausn 100 mg/ml

essential pharma limited - haloperidolum dekanóat - stungulyf, lausn - 100 mg/ml

Haldol Tafla 1 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

haldol tafla 1 mg

essential pharma limited - haloperidolum inn - tafla - 1 mg